title: The soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with plaque psoriasis--does it play any role?
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Batycka-Baran
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Krawczenko
authors.forename: Maria
authors.initials: M
authors.lastname: Paprocka
authors.forename: Wojciech
authors.initials: W
authors.lastname: Baran
authors.forename: Aneta
authors.initials: A
authors.lastname: Kantor
authors.forename: Danuta
authors.initials: D
authors.lastname: Duś
authors.forename: Jacek C
authors.initials: JC
authors.lastname: Szepietowski
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003710:Demography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood*; D012995:Solubility; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood*; D055815:Young Adult
chemical_list: D040281:Vascular Endothelial Growth Factor Receptor-1